GPCR Structure Therapeutics
- 36.590
- -0.850-2.27%
Structure Therapeutics News
Structure Therapeutics | 8-K: Current report
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WELCH DANIEL G
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TETLOW SHARON
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DOBMEIER ERIC
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Waldstreicher Joanne
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LOVE TED W
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Stevens Raymond C
Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner FMR LLC
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Stevens Raymond C
Structure Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Structure Therapeutics | 424B4: Prospectus
Structure Therapeutics | EFFECT: Others
Structure Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lin Xichen
Structure Therapeutics | UPLOAD: Others
Structure Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Structure Therapeutics | 8-K: Current report
Structure Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Structure Therapeutics | CORRESP: CORRESP
Structure Therapeutics | CORRESP: CORRESP
Analysis
Price Target
No Data
